Chronic Pseudomonas Aeruginosa Pulmonary Infections Pipeline Insight 2024 - Pipeline Drug Profiles, Including Clinical and Non-clinical Stage Products
06. Dezember 2024 04:13 ET
|
Research and Markets
Dublin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The "Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2024" has been added to ResearchAndMarkets.com's offering.This report provides...
Developments in Nontuberculous Mycobacterial Infections Pipeline for 2024
25. September 2024 04:07 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Nontuberculous Mycobacterial Infections - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. Nontuberculous...
H. (Helicobacter) Pylori Infection - 2024 Pipeline Insights Report Featuring Emerging Drugs Rifasutenizole (TNP-2198) by TenNor Therapeutics (Suzhou) Limited, and SVT1C4610 by Servatus Biopharmaceuticals
27. August 2024 04:15 ET
|
Research and Markets
Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Helicobacter Pylori Infection - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
Hepatitis B Virus Infection Pipeline Insight Report 2024: Therapeutic Assessment of 80+ Companies and 90+ Drugs
13. August 2024 10:34 ET
|
Research and Markets
Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis B Virus Infection - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "Hepatitis B Virus...
Staphylococcal Infections Therapeutics Report 2024: Comprehensive Insights about 22+ Companies and 23+ Pipeline Drugs
29. Juli 2024 09:45 ET
|
Research and Markets
Dublin, July 29, 2024 (GLOBE NEWSWIRE) -- The "Staphylococcal Infections - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "Staphylococcal Infections...
Cytomegalovirus Infection Therapeutics Research 2024: Comprehensive Insights About 15+ Companies and 20+ Pipeline Drugs Featuring Vir, SpyBiotech, Moderna, VBI, Trellis Bioscience, GSK, & AlloVir
03. Juli 2024 04:10 ET
|
Research and Markets
Dublin, July 03, 2024 (GLOBE NEWSWIRE) -- The "Cytomegalovirus Infection - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Cytomegalovirus...
Innovative Progress in BK Virus (BKV) Infection Pipeline: 2024 Drug Insights - Therapeutic Assessment and Opportunities
18. Juni 2024 10:11 ET
|
Research and Markets
Dublin, June 18, 2024 (GLOBE NEWSWIRE) -- The "BK Virus (BKV) Infection - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The medical community hails the...
2022 Parainfluenza Virus Infection Pipeline Insights: Featuring AlloVir, Ansun Biopharma and Moderna Therapeutics
08. Februar 2023 13:18 ET
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Parainfluenza Virus Infection - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
Carbapenem-Resistant Enterobacteriaceae Infection Market Research Report 2021: Marketed Products, Emerging Therapies, Major Markets, Epidemiology
09. August 2021 04:33 ET
|
Research and Markets
Dublin, Aug. 09, 2021 (GLOBE NEWSWIRE) -- The "Carbapenem-Resistant Enterobacteriaceae Infection - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to...
United States Methicillin Resistant Staphylococcus Aureus (MRSA) Infections Market and Competitive Landscape Report 2021
19. Januar 2021 04:08 ET
|
Research and Markets
Dublin, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The "US Methicillin Resistant Staphylococcus Aureus Infections Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's...